Innovative Technology ProNova Solutions is developing next-generation proton therapy systems that are smaller, lighter, and more energy-efficient, providing an opportunity to offer advanced cancer treatment devices to hospitals and clinics seeking cost-effective, cutting-edge solutions.

Global Expansion Focus With recent collaborations aimed at developing ultra-compact proton therapy systems and active participation in industry events like NPC 2026, ProNova is positioning itself to expand its market reach and establish strategic partnerships worldwide.

Funding & Growth Securing $13.5 million in seed funding and actively developing innovative products indicates strong growth potential and investment interest, making ProNova an attractive prospect for stakeholders looking to invest in the emerging medical equipment sector.

Market Differentiation ProNova’s focus on integrating advanced imaging, superconducting magnet technology, and treatment verification positions it uniquely in the proton therapy market, offering solutions that improve patient outcomes while reducing operational costs, ideal for healthcare providers aiming to upgrade or expand cancer treatment facilities.

Customer Engagement ProNova’s active presence at industry events and strategic partnerships suggest a proactive approach to engaging potential clients and stakeholders, providing multiple opportunities for sales professionals to connect with hospitals, research centers, and healthcare providers interested in innovative cancer treatment technology.